tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Scott Henry, 81 are a BUY (87.1%), 12 are a HOLD (12.9%).
Analyst Scott Henry works with a stock forecast success ratio of 53.09% fulfilled within 147.22 days on average. Previously, Scott Henry worked at ROTH.
Scott Henry’s has documented 180 price targets and ratings displayed on 29 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on DERM, Journey Medical Corp at 16-Feb-2024.
Analyst best performing recommendations are on INVO (INVO BIOSCIENCE).
The best stock recommendation documented was for LGND (LIGAND PHARMACEUTICALS ORPORATED) at 2/4/2021. The price target of $124.77 was fulfilled within 1 day with a profit of $8.54 (7.35%) receiving and performance score of 73.48.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
83
$17.38 (26.49%)
73
1 months 20 days ago
4/6 (66.67%)
$16.58 (24.96%)
148
Buy
80
$14.38 (21.91%)
72
1 months 23 days ago
2/7 (28.57%)
$12.83 (19.10%)
31
Buy
72
$6.38 (9.72%)
72
6 months 5 days ago
3/6 (50%)
$14.69 (25.63%)
89
Buy
49
$-16.62 (-25.33%)
48
11 months 15 days ago
10/11 (90.91%)
$4.59 (10.34%)
474
Hold
42
$-23.62 (-36.00%)
40
11 months 16 days ago
2/3 (66.67%)
$-0.58 (-1.36%)
274
Which stock is Scott Henry is most bullish on?
Which stock is Scott Henry is most reserved on?
What Year was the first public recommendation made by Scott Henry?
